Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
07/2000
07/04/2000US6083750 Adenovirus vectors
07/04/2000US6083749 DNA encoding a human serotonin receptor (5-HT4B) and uses thereof
07/04/2000US6083747 Immobilizing antibody against glycoprotein onto solid support, bringing mixed population of cells into contact with antibody so that wanted stem cells adhere to support, and removing nonadherent cells
07/04/2000US6083746 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells
07/04/2000US6083745 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells
07/04/2000US6083735 Programmed cell death genes and proteins
07/04/2000US6083734 Recombinant xylanase, the preparation and use of thereof
07/04/2000US6083729 Solvent extraction of the biomass to remove the oil and then separating the polyhydroxyalkanoates from the biomass
07/04/2000US6083725 Nucleotide sequences coding a mammalian enzymatic polypeptide; for gene therapy of lysosomal storage defect
07/04/2000US6083719 Cytidine deaminase cDNA as a positive selectable marker for gene transfer, gene therapy and protein synthesis
07/04/2000US6083713 Nucleotide sequences coding binding polypeptide for the terminal domain of the amyloid precursor protein; for the diagnosis and design of drugs for treatment of alzheimer's disease
07/04/2000US6083705 Screening for chemical compound which preferentially binds to binding protein; incubation of compound with cells expressing binding protein, detecting preferential binding of compound to surface of cell not normally expressing binding protein
07/04/2000US6083540 Process for stabilizing proteins in an acidic environment with a high-ester pectin
07/04/2000US6083523 Implantable biocompatable immunoisolatory vehicle for delivery of selected therapeutic products
07/04/2000US6083504 Human monoclonal antibodies directed against the transmembrane glycoprotein (GP41) of human immunodeficiency virus-1 (HIV-1)
07/04/2000US6083502 Methods for detecting the antigen and its expression level as an indication of the presence of tumor cells
07/04/2000US6083499 Pesticidal toxins
07/04/2000US6083478 Consists of a cytotoxic radionuclide and a homodimer comprising two heavy chains encoded by the expression vector designated cd4-igg2-pcdna1 (atcc no. 40952)
07/04/2000US6082364 Pluripotential bone marrow cell line and methods of using the same
06/2000
06/29/2000WO2000037685A2 Method of identifying a psychotropic agent using differential gene expression
06/29/2000WO2000037663A2 Plant transformation process
06/29/2000WO2000037660A1 Methods and genetic compositions to limit outcrossing and undesired gene flow in crop plants
06/29/2000WO2000037648A1 Protective antigen of group a streptococci (spa)
06/29/2000WO2000037646A2 Group b streptococcus proteins, and their use
06/29/2000WO2000037643A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
06/29/2000WO2000037642A1 Method of enhancing the biological activity of ligands
06/29/2000WO2000037640A2 Compositions and methods for the treatment of tumor
06/29/2000WO2000037639A2 Lymphocytic membrane proteins
06/29/2000WO2000037638A2 Methods and compositions for inhibiting neoplastic cell growth
06/29/2000WO2000037635A2 Genetic suppressor elements against human immunodeficiency virus
06/29/2000WO2000037632A1 Monoclonal antibody against apolipoprotein a-i
06/29/2000WO2000037615A1 Recombinant synthesis of beta-lipotropin and other peptides
06/29/2000WO2000037614A2 Variants of egiii-like cellulase and compositions thereof
06/29/2000WO2000037613A2 Human akt-3
06/29/2000WO2000037612A1 SOMATIC CELLS WITH ABLATED Prp GENE AND METHODS OF USE
06/29/2000WO2000037611A1 Cell lineage markers
06/29/2000WO2000037610A2 Expression of immunogenic hepatitis b surface antigens in transgenic plants
06/29/2000WO2000037609A2 Orally immunogenic bacterial enterotoxins expressed in transgenic plants
06/29/2000WO2000037608A2 Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto
06/29/2000WO2000037607A2 Method for producing adipocytes from non-differentiated fibroblasts and use of resulting adipocytes
06/29/2000WO2000037504A2 Human monoclonal antibodies to ctla-4
06/29/2000WO2000037503A1 Compositions and methods for generating monoclonal antibodies representative of a specific cell type
06/29/2000WO2000037494A2 Chlamydia trachomatis antigens
06/29/2000WO2000037493A2 Type iii secretion system antigens from bordetella pertussis
06/29/2000WO2000037491A2 Dnas encoding proteins with signal sequences
06/29/2000WO2000037490A2 Outer surface proteins, their genes, and their use
06/29/2000WO2000037483A1 Protein-protein interactions in neurodegenerative disorders
06/29/2000WO2000037124A1 Injectable hyaluronic acid derivative with pharmaceuticals/cells
06/29/2000WO2000037111A1 Mammalian cell preparations optionally transfected with a gene coding for an active substance containing same
06/29/2000WO2000037095A1 Cardiac muscle function and manipulation
06/29/2000WO2000037060A2 Transgenic plants comprising a conditionally lethal gene
06/29/2000WO2000037025A2 Antibodies to truncated vegf-d and uses thereof
06/29/2000WO2000024437A8 Textured and porous silicone rubber
06/29/2000WO2000017221A9 Method of measuring protein-protein interactions in living cells
06/29/2000WO2000015809A3 Uracil permease from arabidopsis as herbicidal target gene
06/29/2000WO2000015764A3 Propagation and/or derivation of embryonic stem cells
06/29/2000WO2000012726A3 Rationally designed heparinases derived from heparinase i and ii
06/29/2000WO2000012683A3 Stem cells bearing an fgf receptor on the cell surface
06/29/2000WO2000012175A3 Methimazole derivatives and tautomeric cyclic thiones to treat autoimmune diseases
06/29/2000WO2000012113A3 Method of modulating memory effector t-cells using a cd2-binding agent, and compositions
06/29/2000WO2000008187A3 Genes involved in tolerance to environmental stress
06/29/2000WO2000008180A3 HUMAN cDNAs ENCODING POLYPEPTIDES HAVING KINASE FUNCTIONS
06/29/2000WO2000008145A3 Novel genes in control of hematopoiesis
06/29/2000WO2000006717A3 Improved transformation efficiency in phage display through modification of a coat protein
06/29/2000WO2000006605A3 Heterominibodies
06/29/2000WO2000001817A3 Mammalian genes; dendritic cell prostaglandin-like transponder (dc-pgt), hdtea84, hsljd37r and rankl, hcc5 chemokine, deubiquitinating 11 and 12 (dub11, dub12), md-1, md2 and cyclin e2, related reagents and methods
06/29/2000WO2000000610A3 Human signal peptide-containing proteins
06/29/2000WO2000000594A3 Human transferases
06/29/2000WO1999067415A9 Novel molecules of the t110-related protein family and uses thereof
06/29/2000WO1999064579A3 Corn oleosin promoter and genes encoding corn desaturases
06/29/2000WO1999055870A3 Transcription and gene expression regulators
06/29/2000WO1999049019A3 Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics
06/29/2000CA2619682A1 Human monoclonal antibodies to ctla-4
06/29/2000CA2359586A1 Orally immunogenic bacterial enterotoxins expressed in transgenic plants
06/29/2000CA2358086A1 Protein-protein interactions in neurodegenerative disorders
06/29/2000CA2357004A1 Expression of immunogenic hepatitis b surface antigens in transgenic plants
06/29/2000CA2356987A1 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
06/29/2000CA2356764A1 Type iii secretion system antigens from bordetella pertussis
06/29/2000CA2356738A1 Monoclonal antibody against apolipoprotein a-1
06/29/2000CA2356244A1 Somatic cells with ablated prp gene and methods of use
06/29/2000CA2356215A1 Human monoclonal antibodies to ctla-4
06/29/2000CA2356155A1 Cell lineage markers
06/29/2000CA2355896A1 Antibodies to truncated vegf-d and uses thereof
06/29/2000CA2355882A1 Mammalian cell preparations optionally transfected with a gene coding for an active substance containing same
06/29/2000CA2355876A1 Chlamydia trachomatis antigens
06/29/2000CA2355836A1 Genetic suppressor elements against human immunodeficiency virus
06/29/2000CA2355604A1 Novel variant egiii-like cellulase compositions
06/29/2000CA2355402A1 Recombinant synthesis of beta-lipotropin and other peptides
06/29/2000CA2355074A1 Lymphocytic membrane proteins
06/29/2000CA2354846A1 Method of enhancing the biological activity of ligands
06/29/2000CA2354843A1 Outer surface proteins, their genes, and their use
06/29/2000CA2354369A1 Complementary dna's encoding proteins with signal peptides
06/29/2000CA2354185A1 Transgenic plants and methods for production thereof
06/29/2000CA2354135A1 Group b streptococcus proteins, and their use
06/29/2000CA2354074A1 Method of identifying a psychotropic agent using differential gene expression
06/29/2000CA2354030A1 Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto
06/29/2000CA2353799A1 Methods and compositions for inhibiting neoplastic cell growth
06/29/2000CA2353775A1 Compositions and methods for the treatment of tumor
06/29/2000CA2352488A1 Plant transformation process
06/29/2000CA2352471A1 Compositions and methods for generating monoclonal antibodies representative of a specific cell type
1 ... 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 ... 1827